Collections

  • Series |

    The Molecular Diagnostics subject category is edited by Professor David Wynford-Thomas (Leicester, UK) and Dr Lynette Sholl (Boston, USA). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Series |

    The Clinical Subject category is edited by Professor Jeffry Evans (Glasgow, UK) and Professor Stephen Chia (Vancouver, Canada). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Series |

    The Epidemiology subject category is edited by Professor Per Hall (Stockholm, Sweden). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Series |

    The Translational Therapeutics subject category is edited by Dr Suzanne Fuqua (Houston, USA) and Dr Niels Halama (Heidelberg, Germany). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Collection |

    September is Childhood Cancer Awareness Month and in this Collection we highlight a selection of recent papers published in BJC focusing on research into children’s and young people’s cancers covering the epidemiology of cancer occurrence, insights into the molecular mechanisms underlying a variety of cancers affecting children and clinical trials highlighting potential treatments.

  • Series |

    With an ever-growing body of oncology research, BJC Reviews seek to summarise and condense that information into thought-provoking commentaries. They cover a broad remit of oncology research, from the cellular and molecular events that underpin tumorigenesis and disease progression, to existing and emerging therapeutics and clinical cancer management. Our recent review articles are presented for you in this evolving Collection; we hope you enjoy reading them.

    Image: David Becker/ The Image Bank / Getty Images Plus
  • Series |

    The Cellular and Molecular Biology subject category is edited by Professor Margaret Ashcroft (Cambridge, UK). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Series |

    The Genetics and Genomics Subject category is edited by Professor Angela Cox (Sheffield, UK). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Collection |

    This Collection highlights the newest top-viewed content from BJC. Updated each month, we hope you enjoy reading this curated list of articles, which features content from across BJC’s six subject categories. BJC aims to serve as a forum for the sharing and discussion of developments in oncology, by publishing significant advances in translational and clinical cancer research, covering all aspects of cancer prevention, diagnosis, and treatment.

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY
  • Collection |

    The Covid-19 pandemic has had an impact globally, particularly effecting people with underlying medical conditions and weakened immune systems. In this Collection, we bring together our articles on the impact of Covid-19 on cancer.

    Image: Gerd Altmann / Pixabay
  • Collection |

    Programmed cell death 1 receptor (PD-1) and its ligand programmed cell death ligand 1 (PD-L1) are immune checkpoint proteins found on the cell surface of T cells. Under physiological conditions their interaction results in T cell immune suppression, but cancer cells can hijack this pathway to escape immune detection. However, this can be reversed by blocking PD-1’s interaction with PD-L1. This has resulted in an intense research effort to investigate the underlying mechanisms and the clinical utility of inhibitors targeting these checkpoint proteins as therapeutic anticancer drugs. In this Collection we highlight a selection of recent papers focused on the cellular, molecular, diagnostic and clinical effects of these crucial proteins and their inhibitors.

    Image: Image taken from Sahin, I.H., Akce, M., Alese, O. et al. Br J Cancer 121, 809–818 (2019)
  • Collection |

    As an international journal, the British Journal of Cancer publishes articles on a wide range of cancer research from across the world. In this the first Regional Collection, we highlight a selection of recently published studies originating from authors residing in Asia, covering a wide range of subjects from clinical trials through to cell-based studies and from a variety of countries including China, Japan and South Korea and Taiwan among others.